Stocks in Focus

As International Oil Prices Plunge 5%… KoreanAirLines Rises Over 6% [Featured Stocks]

Kim Kyung-eun
2026-07-27 09:15:14
[Edaily Reporter Kim Kyung-eun ] KoreanAirLines(003490)is trading higher in early trading on the 27th amid a sharp drop in international oil prices.



According to MP Doctor, as of 9:10 a.m. today, KoreanAirLines is trading at 27,000 won, up 1,550 won (6.09%) from the previous trading day.

This is interpreted as a result of international oil prices surging nearly 5% after the U.S. and Iran halted mutual attacks for two consecutive days. When oil prices fall, investor sentiment toward airline stocks tends to improve as expectations grow for improved profitability due to reduced fuel costs for airlines.

On the 26th (local time), West Texas Intermediate (WTI) crude futures fell 4.9% to $84.94 per barrel, while Brent crude futures dropped 4.8% to $92.14. This reflects easing concerns over disruptions to Middle Eastern crude oil supplies as tensions in the region have subsided.

The United States, which had been conducting airstrikes for 13 consecutive days, has not carried out any airstrikes against Iran since the 24th. Iran has also stated that it will suspend military retaliation as long as the U.S. continues to refrain from attacking.

Economy

Corporation

IT·Science

Economy

"Going Beyond Legal Approval to Design Shareholder Defenses"... Young M&A 'Key Players'

“Now, when structuring a deal, we must consider not only whether the structure is legally feasible, but also whether we can explain it in a way that allows us to defend it before the board of director…
2026-08-11 07:00:07

Corporation

SK hynix Responds to Rumors of Chongqing Plant Stake Sale: "Nothing Has Been Finalized"

SK hynix has drawn a clear line regarding reports that it is pursuing the sale of its stake in its Chongqing, China, plant, stating, “Nothing has been finalized.” This is the company’s response to a r…
2026-08-10 18:53:57

IT·Science

JointStem: Stalled in Korea but Rapidly Developed in the U.S.—Reasons Behind the Mixed Reactions

Regulatory authorities in South Korea and the United States have reached differing conclusions regarding “JointStem,” a stem cell therapy for degenerative knee osteoarthritis developed by NATURECELL C…
2026-08-11 06:02:02